Skip to main content

Health Care Enforcement in 2015: A Look Back on 2014 and Forecasting the Year Ahead

Mintz Levin

Feb
5
2015

Date: February 5, 2015

Time: 7:00AM - 8:00AM

Location: Webinar

Topics

  • Health Care Enforcement 2014: A Year in Review

Click here to view webinar.

Through their words and actions, the U.S. Department of Justice (DOJ), the Department of Health and Human Services’ Office of Inspector General, and other federal and state agencies confirmed that health care enforcement remained a top priority in 2014. Companies in the health care industry were subject to steep monetary penalties and high dollar settlements, while individuals saw lengthy prison terms, and the imposition of large fines, forfeiture, restitution and settlements. The DOJ further acted on its commitment by announcing that it will seek maximum impact from each investigation, will look to involve as many participants as possible, and will send all qui tam complaints to the Criminal Division for a determination of whether parallel criminal cases should be initiated.

In this webinar, our panelists will discuss these key enforcement trends of 2014 and their likely impact on the activities of these very active agencies in 2015. 

Topics will include:

  • the prioritization of cases against health care providers, including doctors, nurses, and other medical practitioners;
  • the expanding array of criminal charges leveled against companies and individuals to include not only health care fraud, anti-kickback statute violations and false statements, but also identity theft, money laundering, tax violations, structuring, and obstruction of justice;
  • the geographical reach of these actions, as DOJ continues to bring cases across the country ;
  • the continued focus of the DOJ Civil Division on alleged provider and procedure fraud;
  • the continued importance of qui tam relators in health care enforcement; and
  • the lessons to be learned.

Speakers

Professional_Cropped_Foster_Hope_Mintz

Hope S. Foster

Panelist

Hope regularly defends health care companies in governmental investigations and ensuing cases, conducts internal investigations, and advises providers and manufacturers regarding enforcement issues.